Abbott India Sets Record Date For Record Dividend of Rs 475, Chart Is Screaming Breakout; How To Trade?

One of the top pharmaceutical companies in India, Abbott India Limited is a division of Abbott Laboratories and has a significant presence in established pharmaceuticals, medical devices, nutritional products, and diagnostics. Abbott was founded in 1910 and offers a wide range of products to meet different healthcare requirements throughout India. One of D-Street's highest dividend-paying stocks is Abbott India, which paid a substantial dividend of Rs 410 in FY24. The record date for this payment was July 19, 2024. But the corporation has announced that it will pay a final dividend of Rs. 475 for FY25, the largest payout since its founding.

Abbott India Dividend

The Board of Directors have "recommended payment of final dividend of Rs. 475/- per equity share of Rs.10/- each for the financial year ended March 31, 2025, subject to approval of the Shareholders at the ensuing Eighty-first Annual General Meeting of the Company scheduled to be held on Wednesday, August 13, 2025," said Abbott India in a stock exchange filing.

Abbott India Dividend Record Date

"We hereby inform you that the Company has fixed Friday, July 25, 2025, as the Record Date for determining entitlement of Members to Final Dividend for the financial year ended March 31, 2025. The aforesaid Dividend, if approved by the Shareholders at the forthcoming Eighty-first Annual General Meeting of the Company, will be paid on or after Monday, August 18, 2025, to the Members whose names appear on the Register of Members and to the Beneficial Owners of the Shares as on the Record Date, as per the details furnished by the Depositories for this purpose," said Abbott India in a stock exchange filing.

Abbott India Q4 Results

For the fourth quarter that ended on March 31, 2025, the firm recorded a 28 percent rise in profit after tax (PAT) to Rs 367 crore. In the same period last year, it reported a net profit of Rs 287 crore. Revenue from operations increased 11.54% YoY to Rs 1,605 crore in Q4FY25 from Rs 1,439 crore in Q4FY24. EBITDA climbed 22.86% from Rs. 410.68 crore in the year-ago quarter to Rs. 504.56 crore in the quarter under review.

Abbott India announced a net profit of Rs 1,414.44 crore for the entire fiscal year that ended on March 31, 2025, which is a 17.7% increase over the Rs 1,201.22 crore for FY24. In FY25, the total revenue increased to Rs 6,409 crore from Rs 5,849 crore in FY24.

Abbott India Share Price Target

"Abbott India is showing bullish signs after consolidating near the ₹30,000 level. A move above ₹31,000 could lead to a rally toward ₹32,000. The stock is holding above key moving averages, and RSI is showing a rising trend. As long as it stays above ₹30,000, the structure remains positive. A close below that may delay further upside," commented Riyank Arora - Technical Analyst - Mehta Equities Limited.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.